Technical Analysis for BDTX - Black Diamond Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 26.99 -6.61% -1.91
BDTX closed down 6.61 percent on Friday, February 28, 2020, on 52 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical BDTX trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -6.61%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Black Diamond Therapeutics, Inc., a biotechnology company, discover and develops small molecule, tumor-agnostic therapies for cancer treatment. Its lead product candidate is BDTX-189, an inhibitor of non-canonical and oncogenic mutations of ErbB kinases epidermal growth factor receptor (EGFR) and tyrosine-protein kinase. The company is also developing allosteric-EGFR mutation inhibitors; and various early stage pipeline programs of allosteric mutations in kinases related to cancer and/or rare genetic diseases. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.
Biotechnology Cancer Therapies For Cancer Tyrosine Kinase Receptors Enzymes Oncogenes Epidermal Growth Factor Receptor Kinase Rare Genetic Diseases Erbb

Is BDTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 41.79
52 Week Low 26.49
Average Volume 340,277
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 35.97
10-Day Moving Average 33.75
Average True Range 3.42
ADX 0.0
+DI 8.60
-DI 24.10
Chandelier Exit (Long, 3 ATRs ) 31.54
Chandelier Exit (Short, 3 ATRs ) 36.74
Upper Bollinger Band 42.69
Lower Bollinger Band 29.24
Percent B (%b) -0.17
BandWidth 37.40
MACD Line -2.75
MACD Signal Line -1.29
MACD Histogram -1.4583
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 31.12
Resistance 3 (R3) 31.41 30.32 30.43
Resistance 2 (R2) 30.32 29.27 30.18 30.20
Resistance 1 (R1) 28.66 28.62 28.12 28.37 29.97
Pivot Point 27.57 27.57 27.30 27.43 27.57
Support 1 (S1) 25.91 26.52 25.37 25.62 24.01
Support 2 (S2) 24.82 25.87 24.68 23.78
Support 3 (S3) 23.16 24.82 23.55
Support 4 (S4) 22.87